team new

UCL Technology Fund welcomes new life science investors 

UCL Technology Fund (UCLTF) is delighted to announce that Leigh Brody, PhD and Dominik Leisi have joined the fund’s life sciences investment team.

Leigh has 10 years’ experience within life sciences and joins the fund from Quell Therapeutics where until recently she was an Executive Director of Platform Strategy.

Dominik is a welcome addition to the team as part of a one-year secondment from UCL Business (UCLB) where he has spent the past six years as a Project Development Manager.

Leigh and Dominik look forward to working with their colleagues across AlbionVC, UCLB and UCL to support commercialisation opportunities arising from UCL’s world-class research base.

Learn more about Leigh and Dominik on Medium